Abstract:AbstractBackgroundLowe syndrome is a rare X‑linked syndrome that is characterized by involvement of the eyes, central nervous system, and kidneys. The aim of the present study was to determine the molecular basis of four patients with congenital cataract, infantile congenital hypotonia, and proximal renal tubular defect.MethodsFour children who met the clinical manifestations of Lowe syndrome were enrolled in this study. Patients’ clinical information on eyes, central nervous system, kidneys, and family histories, etc., were reviewed and analyzed. After obtaining informed consent, we performed a mutation analysis of OCRL gene using direct sequencing. Because of failure of PCR amplification, low coverage shortread whole genome sequencing (CNVseq) analysis was performed on one proband. Real‐time PCR was subsequently performed to confirm the CNV that was detected from the CNVseq results.ResultsWe identified three OCRL allelic variants, including two novel missense mutations (c.1423C>T/p.Pro475Ser, c.1502T>G/p.Ile501Ser) and one recurrent nonsense mutation (c.2464C>T/p.Arg822Ter). Various bioinformatic tools revealed scores associated with potential pathogenic effects for the two missense variants, and protein alignments revealed that both variants affected an amino acid highly conserved among species. Since deletion of the entire gene was suspected in a patient, CNVseq was used, identifying an interstitial deletion to approximately 190 kb, encompassing OCRL, and SMARCA1 gene. Moreover, the hemizygous CNV was confirmed by qPCR. Reviewing another case reported in the literature, we found that the deletion of OCRL and nearby genes may contribute to a more severe phenotype and premature death.ConclusionsThis is the first report of an interstitial deletion encompassing OCRL and SMARCA1 gene in Lowe syndrome. Our results expand the spectrum of mutations of the OCRL gene in Chinese population. Moreover, whole‐genome sequencing presents a comprehensive and reliable approach for detecting genomic copy number variation in patients or carriers in the family with rare inherited disorders.

Establishment of patient-specific induced pluripotent stem cell line SDUBMSi009-A from a patient with X-linked Lowe syndrome

Generation of Patient-Specific Pluripotent Induced Stem Cell Line SDUBMSI002-A from a Patient with X-linked Mental Retardation Syndrome.

Establishment of an Induced Pluripotent Stem Cell Line (Zjulli004-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYBPC3/c.3764C>A Mutation

Establishment of a Human Induced Pluripotent Stem Cell Line (Csuasoi005-A), from Peripheral Blood Mononuclear Cells of a Patient with X-linked Juvenile Retinoschisis Carrying a Novel Mutation in RS1 Gene.

Establishment of CSUASOi001-A, a Non-Integrated Induced Pluripotent Stem Cell Line from Urine-Derived Cells of a Chinese Patient Carrying RS1 Gene Mutation.

Base editing correction of OCRL in Lowe syndrome: ABE-mediated functional rescue in patient-derived fibroblasts

Whole‐genome Sequencing Revealed an Interstitial Deletion Encompassing OCRL and SMARCA1 Gene in a Patient with Lowe Syndrome

Establishment of a transgene-free iPS cell line (SDQLCHi046-A) from a young patient bearing a HDAC8 mutation and suffering from Cornelia de Lange Syndrome

Establishment of an Induced Pluripotent Stem Cell (ipsc) Line (Inndsui004-A) from a Patient with Congenital Nemaline Myopathy

Novel OCRL mutations in Chinese children with Lowe syndrome

Generation of a Human Induced Pluripotent Stem Cell Line from a Female Patient Carrying LZTR1 Gene Mutation

Establishment of a transgene-free iPS cell line (SDCHi002-A) from a young patient bearing a NPRL3 mutation and suffering from Epilepsy

Establishment of a human induced pluripotent stem cell line (SDQLCHi079-A) from a patient with Johanson-Blizzard syndrome carrying heterozygous mutation in UBR1 gene

Establishment of a non-integrate iPS cell line CSUASOi002-A, from urine-derived cells of a female patient with macular corneal dystrophy carrying compound heterozygous CHST6 mutations.

A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene

Establishment of a non-integrated iPS cell line (SDQLCHi072-A) from a patient suffered from AUTS2 syndrome

Atypical phenotypes and novel OCRL variations in southern Chinese patients with Lowe syndrome

Clinical features and OCRL mutation analysis in a case of infant Lowe syndrome

Identification of the Ocrl1 Gene Mutations in Two Chinese Families with Lowe'S Syndrome

Generation of an induced pluripotent stem cell line (SDQLCHi067-A) from a patient with subcortical band heterotopia harboring a heterozygous mutation in DCX gene

Establishment of Induced Pluripotent Stem Cell Line CSUASOi004-A by Reprogramming Peripheral Blood Mononuclear Cells of a PRPF6-related Dominant Retinitis Pigmentosa Patient.